My Account
Follow us on:
Powered By
Discover 5000+ schemes. Track your portfolio 24X7
Invest Now
MC30 is a curated basket of 30 investment-worthy mutual Fund (MF) schemes.
The new age digital currency to diversify a portfolio.
Visit this section to access live price and charts.
Learn and stay informed about cryptocurrency in India.
Learn More
Learn, discover & invest in smallcases across different types to build your long term portfolio.
Explore from India`s leading investment managers and advisors curating their strategies as smallcases.
Diversify your portfolio by investing in Global brands.
Pre-configured baskets of stocks & ETFs that you can invest in with a single click. Developed by hedge funds, global asset management companies, experienced wealth management firms and portfolio managers.
AMBAREESH BALIGA
Fundamental, Stock Ideas, Multibaggers & Insights
Subscribe
CK NARAYAN
Stock & Index F&O Trading Calls & Market Analysis
SUDARSHAN SUKHANI
Technical Call, Trading Calls & Insights
T GNANASEKAR
Commodity Trading Calls & Market Analysis
MECKLAI FINANCIALS
Currency Derivatives Trading Calls & Insights
SHUBHAM AGARWAL
Options Trading Advice and Market Analysis
MARKET SMITH INDIA
Model portfolios, Investment Ideas, Guru Screens and Much More
TraderSmith
Proprietary system driven Rule Based Trading calls
Curated markets data, exclusive trading recommendations, Independent equity analysis & actionable investment ideas
Explore
STOCK REPORTS BY THOMSON REUTERS
Details stock report and investment recommendation
POWER YOUR TRADE
Technical and Commodity Calls
INVESTMENT WATCH
Set price, volume and news alerts
Nifty 50
17698.15
+39.15 (+0.22%)
Sensex
59462.78
+130.18 (+0.22%)
BSE: 531347 | NSE: | Series: NA | ISIN: | SECTOR: PharmaceuticalsPharmaceuticals
BSE Live
Prev. Close
4.40
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
NSE Live
22.07.2021
Gland Pharma’s new product play for FY22 holds a lot of promise
15.11.2017
Hold Indoco Remedies; target of Rs 250: ICICI Direct
05.10.2017
Buy Natco Pharma; target of Rs 1065: ICICI Direct
18.07.2017
Cipla Q1 PAT may dip 46.52% YoY to Rs 199.6 cr: KR Choksey
28.02.2017
Sanofi India Q4 net declines 58% to Rs 50.5 cr
27.02.2017
Merck Dec-qtr net up 25% at Rs 18 cr
14.02.2017
Claris Lifesciences net profit up 233 pc at Rs 35 cr in Q3
Sun Pharma Q3 profit dragged by slowdown in US & India sales
13.02.2017
Sun Pharma Q3 profit seen up 27%; US & India biz may grow 10%
09.02.2017
Aurobindo Q3 profit seen up 14%, revenue may grow 10% on US biz
Lupin Q3 profit seen up 15% to Rs 609cr, US biz may lift revenue
15.02.2017
Ranbaxy deal to kick in, Halol overhang on Sun Pharma:Brokerages
06.02.2017
Good Q3 but Dr Reddy's still far from sustainable growth: Expert
10.11.2016
Sun Pharma Q2 show healthy but margins unsustainable: Nangra
09.11.2016
Low earnings for Lupin to continue for next 2 qtrs: IIFL